l-thyroxin berlin-chemie
lex ano, uab - levotiroksino natrio druska - tabletės - 50 µg - levothyroxine sodium
pemetrexed ebewe
sandoz d.d. - pemetreksedas - koncentratas infuziniam tirpalui - 25 mg/ml - pemetrexed
l-thyroxin berlin-chemie
lex ano, uab - levotiroksino natrio druska - tabletės - 100 µg - levothyroxine sodium
l-thyroxin berlin-chemie
lex ano, uab - levotiroksino natrio druska - tabletės - 125 µg - levothyroxine sodium
l-thyroxin berlin-chemie
lex ano, uab - levotiroksino natrio druska - tabletės - 75 µg - levothyroxine sodium
pemetrexed zentiva k.s.
zentiva k.s. - pemetreksedas - koncentratas infuziniam tirpalui - 25 mg/ml - pemetrexed
levothyroxine sodium berlin-chemie
berlin-chemie ag - levotiroksino natrio druska - tabletės - 25 µg - levothyroxine sodium
xonvea
exeltis baltics, uab - doksilamino-vandenilio sukcinatas/piridoksino hidrochloridas - skrandyje neirios tabletės - 10 mg/10 mg - doxylamine, combinations
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antinavikiniai vaistai - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
xonvea
exeltis baltics, uab - doksilamino-vandenilio sukcinatas/piridoksino hidrochloridas - modifikuoto atpalaidavimo tabletės - 20 mg/20 mg - doxylamine, combinations